Lakana commences in Kita!

On Thursday, 15 October 2020, CVD-Mali gave the first doses of Lakana study medicine to young participants in Kita.

The Lakana trial, which is being carried out with funding from the Bill & Melinda Gates Foundation, aims to assess the impact azithromycin has on mortality rates in children aged 1-11 months.

The CVD-Mali team have been working tirelessly for many months to make sure that this vitally-important trial can take place and, at last, the first children have been enrolled, and the first doses swallowed !

This image has an empty alt attribute; its file name is WhatsApp-Image-2020-10-15-at-13.52.10-4.jpeg
Administering the very first dose of Lakana study medicine …